Cure My Disease

Don't miss your cure!

 Log in / Sign up

New heart pump could offer lifeline for right heart failure patients

NCT ID NCT07704424

Recruiting now Disease control Sponsor: Shenzhen Core Medical Technology CO.,LTD. Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This trial tests a temporary heart pump called the CorVad system in people with severe right heart failure that does not improve with standard medications. The pump is placed through a blood vessel to help the right ventricle pump blood, giving the heart a chance to recover or bridging patients to a heart transplant or a permanent heart pump. The study includes 6 participants and focuses on safety and whether the device works as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a temporary heart pump called the CorVad Percutaneous Ventricular Assist System (device model CorVad RS) that helps the right ventricle pump blood
What this could lead to
If successful, this device could offer a temporary lifeline for people with severe right heart failure, helping them survive until a heart transplant or other long-term therapy.
What could go wrong
This is a very early, small study with only 6 participants, so results may not apply to all patients. The device carries risks like bleeding, infection, or device malfunction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RIGHT HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cor pulmonale heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RIGHT HEART FAILURE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Anhui Medical University

    NOT_YET_RECRUITING

    Hefei, Anhui, 230022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.